The birth of new cardiac cells

December 5, 2012 in Cardiology

Recent research has shown that there are new cells that develop in the heart, but how these cardiac cells are born and how frequently they are generated remains unclear. In new research from Brigham and Women's Hospital (BWH), researchers use a novel method to identify these new heart cells and describe their origins.

This research is published in Nature on December 5, 2012.

A sophisticated imaging system (MIMS) demonstrates cell division in the adult mammalian heart.

"The question about how often are born has been extremely difficult to answer because there was a need for new techniques to help us understand this process. We are especially excited about our findings because of the novel way in which were able to show new , using Multi-isotope Imaging Mass Spectrometry (MIMS). Our collaborator, Claude Lechene, MD, had developed this technology, and as a team we harnessed this for the cardiac regeneration question." said Richard T. Lee, MD, a physician and researcher in the Cardiovascular Division at BWH and senior author of the paper. "These data present one piece of the puzzle when it comes to the discussion around the generation of new cardiac cells."

The team of BWH researchers marked existing cardiac cells genetically to cause them to express a . Then they used Multi-isotope Imaging (MIMS) to examine the development of new heart muscle cells, called cardiomyocytes, in a pre clinical model over a period of months. Researchers were surprised to find that new heart muscle cells primarily arose from existing , rather than stem cells. Even in the setting of a heart attack, when stem cells are thought to be activated, most new heart cells were born from pre-existing heart cells.

"Our data show that adult cardiomyocytes are primarily responsible for the generation of new cardiomyocytes and that as we age, we lose some capacity to form cells," said Dr. Lee. "This means that we are losing our potential to rebuild the heart in the latter half of life, just when most heart disease hits us. If we can unravel why this occurs, we may be able to unleash some heart regeneration potential."

Journal reference: Nature search and more info website

Provided by Brigham and Women's Hospital search and more info website

5 /5 (1 vote)  

Rank 5 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Costs to treat stroke in America may double by 2030

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.

Cardiology created 3 hours ago | popularity not rated yet | comments 0

New blood-thinner measures may cut medication errors

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Registry questions superiority of bivalirudin over heparin

Results from a large observational study reported at EuroPCR 2013 today question whether bivalirudin is superior to heparin in the absence of GPIIb/IIIa blockade, showing similar 30-day mortality in patients with non-ST segment ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Study shows low rate of late lumen loss with bioresorbable DESolve device

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...

Cardiology created 21 hours ago | popularity 5 / 5 (1) | comments 0


Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis

In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...

Research offers promising new approach to treatment of lung cancer

Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...

Researchers complete largest genetic sequencing study of human disease

Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.

Overeating learned in infancy, study suggests

In the long run, encouraging a baby to finish the last ounce in their bottle might be doing more harm than good.

Researchers analyse hunting behaviour of fish larvae in virtual reality

Moving objects attract greater attention – a fact exploited by video screens in public spaces and animated advertising banners on the Internet. For most animal species, moving objects also play a major ...